2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Molecular Mechanisms of Chronic Kidney Graft Injury

141.9 - Increased number of glomerular (G) CD68 + cells is the single most sensitive predictor of transplant glomerulopathy (TG) and graft loss

Presenter: John, Papadimitriou, Baltimore, United States
Authors: Papadimitriou J., Drachenberg C., Haririan A., Munivenkatappa R.

INCREASED NUMBER OF GLOMERULAR (G) CD68 + CELLS IS THE SINGLE MOST SENSITIVE PREDICTOR OF TRANSPLANT GLOMERULOPATHY (TG) AND GRAFT LOSS

MOLECULAR MECHANISMS OF CHRONIC KIDNEY GRAFT INJURY

J.C. Papadimitriou1, C. Drachenberg2, A. Haririan3, R. Munivenkatappa4
1Pathology, University of Maryland School of Medicine, Baltimore/UNITED STATES OF AMERICA, 2Pathology, University of Maryland School of Medicine, Baltimore/MD/UNITED STATES OF AMERICA, 3Medicine, University of Maryland School of Medicine, Baltimore/MD/UNITED STATES OF AMERICA, 4, University of Maryland School of Medicine, Baltimore/MD/UNITED STATES OF AMERICA

Body: Introduction: TG is the most characteristic and important histological feature of chronic antibody mediated rejection (AMR). Its pathogenesis and early morphological recognition is a subject of significant academic as well as clinical/diagnostic relevance. Methods: Biopsies (Bx) from 240 patients with grafts functioning for ≥1 year (1-6 Bx/ patient,n=649) were examined with routine stains, C4d stain and electron microscopy (EM). In addition, CD3, CD20 and CD68 stains were done in all Bx in order to identify T and B lymphocytes and macrophages respectively. For each patient the Bx with earliest G pathology or the last Bx if no G pathology was present, was selected and inflammatory cells were quantitated in the least and most inflamed G. Results: Based on the G pathology Bx were classified in eight groups: normal 20.8% (n=50), ischemic 30.8% (n=74), diabetic glomerulosclerosis (DG) 8.4%, various types of glomerulonephritis (GN) 7%, FSGS 8.4%, transplant glomerulitis (TGitis) 6.6%, TG 16.3% and thrombotic microangiopathy 1.7%. TG had a significantly higher number of C68+ cells compared to all other categories (p=.015 vs TGitis, p=.001 vs. all others). Similarly, CD3+ were higher in TG than all other goups except TGitis, but much less so than CD68+. The number of neutrophils correlated with CD68+ (r=.61) but by themselves neutrophils did not discriminate TG from other pathologies. Using ROC analysis a cutoff of CD68 of >12 in the most inflamed glomerulus was the most reliable predictor of TG (84.6% sensitive and 86.7% specific), even more than DSA. This value correlated strongly with DSA (p=.001), C4d staining in peritubular capillaries (PTC) (p=.001), PTC multilamellation on EM (p<.001), diffuse C4d staining in G loops (p=.005), Banff “g” scores (p<.001) and Banff “cg” scores (between 0 vs. the other scores (p<.001), indicating that macrophages correlate linearly more with activity than chronicity). CD68>12 was also associated with worse graft survival (mean follow-up 13.8 mo), even after adjusting for potential confounders including degree of interstitial fibrosis and inflammation, PTC C4d staining, TG and DSA (HR=2.16, P=0.016, 95%CI:1.2-4.0). Interestingly, after adjustment for glomerular CD68>12, DSA was no longer independently predictive of graft loss (HR:1.3, P=0.33; 95%CI:0.7-2.4). In contrast to the number of CD68+ cells, Banff g score was not significantly associated with graft failure.

Conclusions: CD68Max >12 appears to be the most sensitive predictor of TG, even more than DSA, and independently associated with graft survival. Although multilammelation of PTC on EM of >5 layers was more specific, a combination of CD68Max>12 and C4d in PTC had comparable specificity to EM. Thus, the number of G CD68 + cells appears to be of both diagnostic as well as pathogenetic/mechanistic importance for TG and overall graft survival.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada